CoQ10 may improve kidney healthThe protective role of coenzyme Q10 in renal injury associated with extracorporeal shockwave lithotripsy: a randomised, placebo-controlled clinical trial.
Study addresses kidney treatment impacts.
We explored the effectiveness of coenzyme Q10 (CoQ10) in protecting renal function in patients dealing with kidney stones who underwent extracorporeal shockwave lithotripsy (ESWL). Our study involved 100 participants randomly assigned to receive either CoQ10 or a placebo, helping us compare the outcomes of each group.
Over the course of the study, we saw promising results from those who took CoQ10. There was a significant improvement in kidney function markers, such as a notable increase in glomerular filtration. Additionally, levels of certain hormones and interleukins linked to blood vessel function and inflammation showed enhancement in the CoQ10 group, contributing to the overall health of the kidneys after the procedure.
However, it’s important to mention that we did not observe significant changes in oxidative stress parameters, which means that while CoQ10 helped with kidney function, it didn't seem to reduce oxidative stress levels as expected. Nonetheless, this research highlights the potential of CoQ10 as a protective agent for the kidneys during treatments like ESWL, suggesting a beneficial preconditioning effect before such procedures.
Read More